nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirtazapine—Azatadine—Loratadine—atopic dermatitis	0.399	1	CrCrCtD
Mirtazapine—HRH1—Dimenhydrinate—atopic dermatitis	0.0665	0.186	CbGbCtD
Mirtazapine—CYP2C8—Mometasone—atopic dermatitis	0.0354	0.0988	CbGbCtD
Mirtazapine—HRH1—Loratadine—atopic dermatitis	0.0325	0.0906	CbGbCtD
Mirtazapine—HRH1—Diphenhydramine—atopic dermatitis	0.0325	0.0906	CbGbCtD
Mirtazapine—CYP2C8—Loratadine—atopic dermatitis	0.0203	0.0567	CbGbCtD
Mirtazapine—CYP3A4—Pimecrolimus—atopic dermatitis	0.0189	0.0529	CbGbCtD
Mirtazapine—CYP1A2—Diphenhydramine—atopic dermatitis	0.0157	0.0439	CbGbCtD
Mirtazapine—CYP2C9—Loratadine—atopic dermatitis	0.0142	0.0396	CbGbCtD
Mirtazapine—CYP2C9—Diphenhydramine—atopic dermatitis	0.0142	0.0396	CbGbCtD
Mirtazapine—CYP2D6—Loratadine—atopic dermatitis	0.013	0.0362	CbGbCtD
Mirtazapine—CYP2D6—Diphenhydramine—atopic dermatitis	0.013	0.0362	CbGbCtD
Mirtazapine—CYP2C8—Hydrocortisone—atopic dermatitis	0.0113	0.0316	CbGbCtD
Mirtazapine—CYP3A4—Tacrolimus—atopic dermatitis	0.0113	0.0314	CbGbCtD
Mirtazapine—CYP3A4—Loratadine—atopic dermatitis	0.00824	0.023	CbGbCtD
Mirtazapine—CYP3A4—Methylprednisolone—atopic dermatitis	0.00754	0.021	CbGbCtD
Mirtazapine—CYP2C8—Dexamethasone—atopic dermatitis	0.00703	0.0196	CbGbCtD
Mirtazapine—CYP3A4—Triamcinolone—atopic dermatitis	0.00571	0.0159	CbGbCtD
Mirtazapine—CYP2C9—Dexamethasone—atopic dermatitis	0.0049	0.0137	CbGbCtD
Mirtazapine—CYP3A4—Betamethasone—atopic dermatitis	0.0049	0.0137	CbGbCtD
Mirtazapine—CYP3A4—Prednisolone—atopic dermatitis	0.00484	0.0135	CbGbCtD
Mirtazapine—CYP3A4—Hydrocortisone—atopic dermatitis	0.00458	0.0128	CbGbCtD
Mirtazapine—CYP3A4—Prednisone—atopic dermatitis	0.00457	0.0127	CbGbCtD
Mirtazapine—CYP2D6—Dexamethasone—atopic dermatitis	0.00448	0.0125	CbGbCtD
Mirtazapine—CYP3A4—Dexamethasone—atopic dermatitis	0.00285	0.00796	CbGbCtD
Mirtazapine—Oedema—Prednisolone—atopic dermatitis	6.08e-05	0.000336	CcSEcCtD
Mirtazapine—Vomiting—Tacrolimus—atopic dermatitis	6.06e-05	0.000334	CcSEcCtD
Mirtazapine—Loss of consciousness—Triamcinolone—atopic dermatitis	6.02e-05	0.000332	CcSEcCtD
Mirtazapine—Loss of consciousness—Methylprednisolone—atopic dermatitis	6.01e-05	0.000332	CcSEcCtD
Mirtazapine—Rash—Tacrolimus—atopic dermatitis	6.01e-05	0.000331	CcSEcCtD
Mirtazapine—Dermatitis—Tacrolimus—atopic dermatitis	6e-05	0.000331	CcSEcCtD
Mirtazapine—Shock—Prednisolone—atopic dermatitis	5.99e-05	0.00033	CcSEcCtD
Mirtazapine—Cough—Triamcinolone—atopic dermatitis	5.98e-05	0.00033	CcSEcCtD
Mirtazapine—Headache—Tacrolimus—atopic dermatitis	5.97e-05	0.000329	CcSEcCtD
Mirtazapine—Oedema—Hydrocortisone—atopic dermatitis	5.94e-05	0.000328	CcSEcCtD
Mirtazapine—Convulsion—Triamcinolone—atopic dermatitis	5.94e-05	0.000328	CcSEcCtD
Mirtazapine—Tachycardia—Prednisolone—atopic dermatitis	5.94e-05	0.000328	CcSEcCtD
Mirtazapine—Convulsion—Methylprednisolone—atopic dermatitis	5.93e-05	0.000327	CcSEcCtD
Mirtazapine—Hypertension—Triamcinolone—atopic dermatitis	5.92e-05	0.000327	CcSEcCtD
Mirtazapine—Hypertension—Methylprednisolone—atopic dermatitis	5.91e-05	0.000326	CcSEcCtD
Mirtazapine—Infection—Hydrocortisone—atopic dermatitis	5.9e-05	0.000326	CcSEcCtD
Mirtazapine—Hyperhidrosis—Prednisolone—atopic dermatitis	5.88e-05	0.000324	CcSEcCtD
Mirtazapine—Shock—Hydrocortisone—atopic dermatitis	5.85e-05	0.000322	CcSEcCtD
Mirtazapine—Myalgia—Triamcinolone—atopic dermatitis	5.84e-05	0.000322	CcSEcCtD
Mirtazapine—Nervous system disorder—Hydrocortisone—atopic dermatitis	5.83e-05	0.000321	CcSEcCtD
Mirtazapine—Myalgia—Methylprednisolone—atopic dermatitis	5.82e-05	0.000321	CcSEcCtD
Mirtazapine—Arthralgia—Methylprednisolone—atopic dermatitis	5.82e-05	0.000321	CcSEcCtD
Mirtazapine—Eye disorder—Prednisone—atopic dermatitis	5.82e-05	0.000321	CcSEcCtD
Mirtazapine—Anxiety—Methylprednisolone—atopic dermatitis	5.8e-05	0.00032	CcSEcCtD
Mirtazapine—Tachycardia—Hydrocortisone—atopic dermatitis	5.8e-05	0.00032	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	5.78e-05	0.000319	CcSEcCtD
Mirtazapine—Skin disorder—Hydrocortisone—atopic dermatitis	5.77e-05	0.000318	CcSEcCtD
Mirtazapine—Ill-defined disorder—Dexamethasone—atopic dermatitis	5.77e-05	0.000318	CcSEcCtD
Mirtazapine—Ill-defined disorder—Betamethasone—atopic dermatitis	5.77e-05	0.000318	CcSEcCtD
Mirtazapine—Discomfort—Triamcinolone—atopic dermatitis	5.77e-05	0.000318	CcSEcCtD
Mirtazapine—Discomfort—Methylprednisolone—atopic dermatitis	5.75e-05	0.000317	CcSEcCtD
Mirtazapine—Hyperhidrosis—Hydrocortisone—atopic dermatitis	5.74e-05	0.000317	CcSEcCtD
Mirtazapine—Dry mouth—Triamcinolone—atopic dermatitis	5.71e-05	0.000315	CcSEcCtD
Mirtazapine—Anorexia—Hydrocortisone—atopic dermatitis	5.66e-05	0.000312	CcSEcCtD
Mirtazapine—Nausea—Tacrolimus—atopic dermatitis	5.66e-05	0.000312	CcSEcCtD
Mirtazapine—Angiopathy—Prednisone—atopic dermatitis	5.65e-05	0.000311	CcSEcCtD
Mirtazapine—Confusional state—Methylprednisolone—atopic dermatitis	5.63e-05	0.000311	CcSEcCtD
Mirtazapine—Malaise—Dexamethasone—atopic dermatitis	5.61e-05	0.000309	CcSEcCtD
Mirtazapine—Malaise—Betamethasone—atopic dermatitis	5.61e-05	0.000309	CcSEcCtD
Mirtazapine—Oedema—Triamcinolone—atopic dermatitis	5.59e-05	0.000309	CcSEcCtD
Mirtazapine—Vertigo—Dexamethasone—atopic dermatitis	5.59e-05	0.000308	CcSEcCtD
Mirtazapine—Vertigo—Betamethasone—atopic dermatitis	5.59e-05	0.000308	CcSEcCtD
Mirtazapine—Syncope—Dexamethasone—atopic dermatitis	5.58e-05	0.000308	CcSEcCtD
Mirtazapine—Syncope—Betamethasone—atopic dermatitis	5.58e-05	0.000308	CcSEcCtD
Mirtazapine—Arrhythmia—Prednisone—atopic dermatitis	5.56e-05	0.000307	CcSEcCtD
Mirtazapine—Infection—Triamcinolone—atopic dermatitis	5.56e-05	0.000307	CcSEcCtD
Mirtazapine—Hypotension—Hydrocortisone—atopic dermatitis	5.55e-05	0.000306	CcSEcCtD
Mirtazapine—Infection—Methylprednisolone—atopic dermatitis	5.55e-05	0.000306	CcSEcCtD
Mirtazapine—Shock—Triamcinolone—atopic dermatitis	5.5e-05	0.000304	CcSEcCtD
Mirtazapine—Insomnia—Prednisolone—atopic dermatitis	5.5e-05	0.000304	CcSEcCtD
Mirtazapine—Alopecia—Prednisone—atopic dermatitis	5.5e-05	0.000303	CcSEcCtD
Mirtazapine—Shock—Methylprednisolone—atopic dermatitis	5.49e-05	0.000303	CcSEcCtD
Mirtazapine—Nervous system disorder—Methylprednisolone—atopic dermatitis	5.47e-05	0.000302	CcSEcCtD
Mirtazapine—Loss of consciousness—Betamethasone—atopic dermatitis	5.47e-05	0.000302	CcSEcCtD
Mirtazapine—Loss of consciousness—Dexamethasone—atopic dermatitis	5.47e-05	0.000302	CcSEcCtD
Mirtazapine—Paraesthesia—Prednisolone—atopic dermatitis	5.46e-05	0.000301	CcSEcCtD
Mirtazapine—Tachycardia—Triamcinolone—atopic dermatitis	5.46e-05	0.000301	CcSEcCtD
Mirtazapine—Mental disorder—Prednisone—atopic dermatitis	5.45e-05	0.000301	CcSEcCtD
Mirtazapine—Tachycardia—Methylprednisolone—atopic dermatitis	5.45e-05	0.000301	CcSEcCtD
Mirtazapine—Skin disorder—Methylprednisolone—atopic dermatitis	5.42e-05	0.000299	CcSEcCtD
Mirtazapine—Malnutrition—Prednisone—atopic dermatitis	5.42e-05	0.000299	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	5.41e-05	0.000299	CcSEcCtD
Mirtazapine—Hyperhidrosis—Triamcinolone—atopic dermatitis	5.41e-05	0.000298	CcSEcCtD
Mirtazapine—Hyperhidrosis—Methylprednisolone—atopic dermatitis	5.4e-05	0.000298	CcSEcCtD
Mirtazapine—Convulsion—Dexamethasone—atopic dermatitis	5.39e-05	0.000297	CcSEcCtD
Mirtazapine—Convulsion—Betamethasone—atopic dermatitis	5.39e-05	0.000297	CcSEcCtD
Mirtazapine—Insomnia—Hydrocortisone—atopic dermatitis	5.37e-05	0.000296	CcSEcCtD
Mirtazapine—Hypertension—Betamethasone—atopic dermatitis	5.37e-05	0.000296	CcSEcCtD
Mirtazapine—Hypertension—Dexamethasone—atopic dermatitis	5.37e-05	0.000296	CcSEcCtD
Mirtazapine—Paraesthesia—Hydrocortisone—atopic dermatitis	5.34e-05	0.000294	CcSEcCtD
Mirtazapine—Myalgia—Betamethasone—atopic dermatitis	5.3e-05	0.000292	CcSEcCtD
Mirtazapine—Myalgia—Dexamethasone—atopic dermatitis	5.3e-05	0.000292	CcSEcCtD
Mirtazapine—Anxiety—Dexamethasone—atopic dermatitis	5.28e-05	0.000291	CcSEcCtD
Mirtazapine—Anxiety—Betamethasone—atopic dermatitis	5.28e-05	0.000291	CcSEcCtD
Mirtazapine—Discomfort—Dexamethasone—atopic dermatitis	5.23e-05	0.000289	CcSEcCtD
Mirtazapine—Discomfort—Betamethasone—atopic dermatitis	5.23e-05	0.000289	CcSEcCtD
Mirtazapine—Dyspepsia—Hydrocortisone—atopic dermatitis	5.23e-05	0.000289	CcSEcCtD
Mirtazapine—Hypotension—Methylprednisolone—atopic dermatitis	5.22e-05	0.000288	CcSEcCtD
Mirtazapine—Pain—Prednisolone—atopic dermatitis	5.2e-05	0.000287	CcSEcCtD
Mirtazapine—Decreased appetite—Hydrocortisone—atopic dermatitis	5.16e-05	0.000285	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	5.13e-05	0.000283	CcSEcCtD
Mirtazapine—Fatigue—Hydrocortisone—atopic dermatitis	5.12e-05	0.000283	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	5.1e-05	0.000281	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	5.09e-05	0.000281	CcSEcCtD
Mirtazapine—Pain—Hydrocortisone—atopic dermatitis	5.08e-05	0.00028	CcSEcCtD
Mirtazapine—Oedema—Dexamethasone—atopic dermatitis	5.08e-05	0.00028	CcSEcCtD
Mirtazapine—Oedema—Betamethasone—atopic dermatitis	5.08e-05	0.00028	CcSEcCtD
Mirtazapine—Insomnia—Triamcinolone—atopic dermatitis	5.06e-05	0.000279	CcSEcCtD
Mirtazapine—Insomnia—Methylprednisolone—atopic dermatitis	5.05e-05	0.000279	CcSEcCtD
Mirtazapine—Infection—Dexamethasone—atopic dermatitis	5.04e-05	0.000278	CcSEcCtD
Mirtazapine—Infection—Betamethasone—atopic dermatitis	5.04e-05	0.000278	CcSEcCtD
Mirtazapine—Ill-defined disorder—Prednisone—atopic dermatitis	5.03e-05	0.000277	CcSEcCtD
Mirtazapine—Paraesthesia—Triamcinolone—atopic dermatitis	5.02e-05	0.000277	CcSEcCtD
Mirtazapine—Feeling abnormal—Prednisolone—atopic dermatitis	5.01e-05	0.000277	CcSEcCtD
Mirtazapine—Paraesthesia—Methylprednisolone—atopic dermatitis	5.01e-05	0.000277	CcSEcCtD
Mirtazapine—Anaemia—Prednisone—atopic dermatitis	5.01e-05	0.000276	CcSEcCtD
Mirtazapine—Shock—Dexamethasone—atopic dermatitis	4.99e-05	0.000276	CcSEcCtD
Mirtazapine—Shock—Betamethasone—atopic dermatitis	4.99e-05	0.000276	CcSEcCtD
Mirtazapine—Dyspnoea—Triamcinolone—atopic dermatitis	4.99e-05	0.000275	CcSEcCtD
Mirtazapine—Nervous system disorder—Betamethasone—atopic dermatitis	4.98e-05	0.000275	CcSEcCtD
Mirtazapine—Nervous system disorder—Dexamethasone—atopic dermatitis	4.98e-05	0.000275	CcSEcCtD
Mirtazapine—Agitation—Prednisone—atopic dermatitis	4.98e-05	0.000275	CcSEcCtD
Mirtazapine—Thrombocytopenia—Dexamethasone—atopic dermatitis	4.97e-05	0.000274	CcSEcCtD
Mirtazapine—Thrombocytopenia—Betamethasone—atopic dermatitis	4.97e-05	0.000274	CcSEcCtD
Mirtazapine—Tachycardia—Dexamethasone—atopic dermatitis	4.95e-05	0.000273	CcSEcCtD
Mirtazapine—Tachycardia—Betamethasone—atopic dermatitis	4.95e-05	0.000273	CcSEcCtD
Mirtazapine—Dyspepsia—Triamcinolone—atopic dermatitis	4.92e-05	0.000272	CcSEcCtD
Mirtazapine—Dyspepsia—Methylprednisolone—atopic dermatitis	4.91e-05	0.000271	CcSEcCtD
Mirtazapine—Hyperhidrosis—Dexamethasone—atopic dermatitis	4.91e-05	0.000271	CcSEcCtD
Mirtazapine—Hyperhidrosis—Betamethasone—atopic dermatitis	4.91e-05	0.000271	CcSEcCtD
Mirtazapine—Feeling abnormal—Hydrocortisone—atopic dermatitis	4.9e-05	0.00027	CcSEcCtD
Mirtazapine—Malaise—Prednisone—atopic dermatitis	4.88e-05	0.000269	CcSEcCtD
Mirtazapine—Vertigo—Prednisone—atopic dermatitis	4.87e-05	0.000268	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	4.86e-05	0.000268	CcSEcCtD
Mirtazapine—Syncope—Prednisone—atopic dermatitis	4.86e-05	0.000268	CcSEcCtD
Mirtazapine—Anorexia—Dexamethasone—atopic dermatitis	4.84e-05	0.000267	CcSEcCtD
Mirtazapine—Anorexia—Betamethasone—atopic dermatitis	4.84e-05	0.000267	CcSEcCtD
Mirtazapine—Urticaria—Prednisolone—atopic dermatitis	4.83e-05	0.000267	CcSEcCtD
Mirtazapine—Fatigue—Triamcinolone—atopic dermatitis	4.82e-05	0.000266	CcSEcCtD
Mirtazapine—Fatigue—Methylprednisolone—atopic dermatitis	4.81e-05	0.000266	CcSEcCtD
Mirtazapine—Pain—Triamcinolone—atopic dermatitis	4.78e-05	0.000264	CcSEcCtD
Mirtazapine—Loss of consciousness—Prednisone—atopic dermatitis	4.76e-05	0.000263	CcSEcCtD
Mirtazapine—Hypotension—Dexamethasone—atopic dermatitis	4.74e-05	0.000262	CcSEcCtD
Mirtazapine—Hypotension—Betamethasone—atopic dermatitis	4.74e-05	0.000262	CcSEcCtD
Mirtazapine—Urticaria—Hydrocortisone—atopic dermatitis	4.72e-05	0.00026	CcSEcCtD
Mirtazapine—Abdominal pain—Hydrocortisone—atopic dermatitis	4.7e-05	0.000259	CcSEcCtD
Mirtazapine—Body temperature increased—Hydrocortisone—atopic dermatitis	4.7e-05	0.000259	CcSEcCtD
Mirtazapine—Convulsion—Prednisone—atopic dermatitis	4.69e-05	0.000259	CcSEcCtD
Mirtazapine—Hypertension—Prednisone—atopic dermatitis	4.68e-05	0.000258	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	4.62e-05	0.000255	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	4.62e-05	0.000255	CcSEcCtD
Mirtazapine—Myalgia—Prednisone—atopic dermatitis	4.61e-05	0.000254	CcSEcCtD
Mirtazapine—Arthralgia—Prednisone—atopic dermatitis	4.61e-05	0.000254	CcSEcCtD
Mirtazapine—Feeling abnormal—Triamcinolone—atopic dermatitis	4.61e-05	0.000254	CcSEcCtD
Mirtazapine—Feeling abnormal—Methylprednisolone—atopic dermatitis	4.6e-05	0.000254	CcSEcCtD
Mirtazapine—Anxiety—Prednisone—atopic dermatitis	4.6e-05	0.000254	CcSEcCtD
Mirtazapine—Insomnia—Dexamethasone—atopic dermatitis	4.59e-05	0.000253	CcSEcCtD
Mirtazapine—Insomnia—Betamethasone—atopic dermatitis	4.59e-05	0.000253	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	4.58e-05	0.000253	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	4.56e-05	0.000252	CcSEcCtD
Mirtazapine—Paraesthesia—Dexamethasone—atopic dermatitis	4.56e-05	0.000251	CcSEcCtD
Mirtazapine—Paraesthesia—Betamethasone—atopic dermatitis	4.56e-05	0.000251	CcSEcCtD
Mirtazapine—Discomfort—Prednisone—atopic dermatitis	4.56e-05	0.000251	CcSEcCtD
Mirtazapine—Hypersensitivity—Prednisolone—atopic dermatitis	4.48e-05	0.000247	CcSEcCtD
Mirtazapine—Dyspepsia—Dexamethasone—atopic dermatitis	4.47e-05	0.000247	CcSEcCtD
Mirtazapine—Dyspepsia—Betamethasone—atopic dermatitis	4.47e-05	0.000247	CcSEcCtD
Mirtazapine—Urticaria—Triamcinolone—atopic dermatitis	4.44e-05	0.000245	CcSEcCtD
Mirtazapine—Urticaria—Methylprednisolone—atopic dermatitis	4.43e-05	0.000245	CcSEcCtD
Mirtazapine—Body temperature increased—Triamcinolone—atopic dermatitis	4.42e-05	0.000244	CcSEcCtD
Mirtazapine—Oedema—Prednisone—atopic dermatitis	4.42e-05	0.000244	CcSEcCtD
Mirtazapine—Abdominal pain—Methylprednisolone—atopic dermatitis	4.41e-05	0.000243	CcSEcCtD
Mirtazapine—Decreased appetite—Betamethasone—atopic dermatitis	4.41e-05	0.000243	CcSEcCtD
Mirtazapine—Decreased appetite—Dexamethasone—atopic dermatitis	4.41e-05	0.000243	CcSEcCtD
Mirtazapine—Infection—Prednisone—atopic dermatitis	4.39e-05	0.000242	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	4.38e-05	0.000242	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Betamethasone—atopic dermatitis	4.38e-05	0.000242	CcSEcCtD
Mirtazapine—Hypersensitivity—Hydrocortisone—atopic dermatitis	4.38e-05	0.000242	CcSEcCtD
Mirtazapine—Fatigue—Betamethasone—atopic dermatitis	4.38e-05	0.000241	CcSEcCtD
Mirtazapine—Fatigue—Dexamethasone—atopic dermatitis	4.38e-05	0.000241	CcSEcCtD
Mirtazapine—Shock—Prednisone—atopic dermatitis	4.35e-05	0.00024	CcSEcCtD
Mirtazapine—Pain—Dexamethasone—atopic dermatitis	4.34e-05	0.000239	CcSEcCtD
Mirtazapine—Pain—Betamethasone—atopic dermatitis	4.34e-05	0.000239	CcSEcCtD
Mirtazapine—Nervous system disorder—Prednisone—atopic dermatitis	4.34e-05	0.000239	CcSEcCtD
Mirtazapine—Tachycardia—Prednisone—atopic dermatitis	4.31e-05	0.000238	CcSEcCtD
Mirtazapine—Skin disorder—Prednisone—atopic dermatitis	4.29e-05	0.000237	CcSEcCtD
Mirtazapine—Hyperhidrosis—Prednisone—atopic dermatitis	4.27e-05	0.000236	CcSEcCtD
Mirtazapine—Asthenia—Hydrocortisone—atopic dermatitis	4.26e-05	0.000235	CcSEcCtD
Mirtazapine—Anorexia—Prednisone—atopic dermatitis	4.21e-05	0.000232	CcSEcCtD
Mirtazapine—Pruritus—Hydrocortisone—atopic dermatitis	4.2e-05	0.000232	CcSEcCtD
Mirtazapine—Feeling abnormal—Dexamethasone—atopic dermatitis	4.18e-05	0.000231	CcSEcCtD
Mirtazapine—Feeling abnormal—Betamethasone—atopic dermatitis	4.18e-05	0.000231	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Dexamethasone—atopic dermatitis	4.15e-05	0.000229	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Betamethasone—atopic dermatitis	4.15e-05	0.000229	CcSEcCtD
Mirtazapine—Hypersensitivity—Triamcinolone—atopic dermatitis	4.12e-05	0.000227	CcSEcCtD
Mirtazapine—Hypersensitivity—Methylprednisolone—atopic dermatitis	4.11e-05	0.000227	CcSEcCtD
Mirtazapine—Diarrhoea—Hydrocortisone—atopic dermatitis	4.07e-05	0.000224	CcSEcCtD
Mirtazapine—Urticaria—Dexamethasone—atopic dermatitis	4.03e-05	0.000222	CcSEcCtD
Mirtazapine—Urticaria—Betamethasone—atopic dermatitis	4.03e-05	0.000222	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Prednisone—atopic dermatitis	4.03e-05	0.000222	CcSEcCtD
Mirtazapine—Dizziness—Prednisolone—atopic dermatitis	4.02e-05	0.000222	CcSEcCtD
Mirtazapine—Asthenia—Triamcinolone—atopic dermatitis	4.01e-05	0.000221	CcSEcCtD
Mirtazapine—Body temperature increased—Betamethasone—atopic dermatitis	4.01e-05	0.000221	CcSEcCtD
Mirtazapine—Body temperature increased—Dexamethasone—atopic dermatitis	4.01e-05	0.000221	CcSEcCtD
Mirtazapine—Abdominal pain—Dexamethasone—atopic dermatitis	4.01e-05	0.000221	CcSEcCtD
Mirtazapine—Abdominal pain—Betamethasone—atopic dermatitis	4.01e-05	0.000221	CcSEcCtD
Mirtazapine—Asthenia—Methylprednisolone—atopic dermatitis	4.01e-05	0.000221	CcSEcCtD
Mirtazapine—Insomnia—Prednisone—atopic dermatitis	4e-05	0.000221	CcSEcCtD
Mirtazapine—Paraesthesia—Prednisone—atopic dermatitis	3.97e-05	0.000219	CcSEcCtD
Mirtazapine—Pruritus—Triamcinolone—atopic dermatitis	3.96e-05	0.000218	CcSEcCtD
Mirtazapine—Pruritus—Methylprednisolone—atopic dermatitis	3.95e-05	0.000218	CcSEcCtD
Mirtazapine—Dizziness—Hydrocortisone—atopic dermatitis	3.93e-05	0.000217	CcSEcCtD
Mirtazapine—Dyspepsia—Prednisone—atopic dermatitis	3.89e-05	0.000215	CcSEcCtD
Mirtazapine—Decreased appetite—Prednisone—atopic dermatitis	3.84e-05	0.000212	CcSEcCtD
Mirtazapine—Rash—Prednisolone—atopic dermatitis	3.84e-05	0.000212	CcSEcCtD
Mirtazapine—Dermatitis—Prednisolone—atopic dermatitis	3.83e-05	0.000211	CcSEcCtD
Mirtazapine—Diarrhoea—Methylprednisolone—atopic dermatitis	3.82e-05	0.000211	CcSEcCtD
Mirtazapine—Fatigue—Prednisone—atopic dermatitis	3.81e-05	0.00021	CcSEcCtD
Mirtazapine—Headache—Prednisolone—atopic dermatitis	3.81e-05	0.00021	CcSEcCtD
Mirtazapine—Constipation—Prednisone—atopic dermatitis	3.78e-05	0.000209	CcSEcCtD
Mirtazapine—Vomiting—Hydrocortisone—atopic dermatitis	3.78e-05	0.000208	CcSEcCtD
Mirtazapine—Rash—Hydrocortisone—atopic dermatitis	3.75e-05	0.000207	CcSEcCtD
Mirtazapine—Dermatitis—Hydrocortisone—atopic dermatitis	3.74e-05	0.000206	CcSEcCtD
Mirtazapine—Headache—Hydrocortisone—atopic dermatitis	3.72e-05	0.000205	CcSEcCtD
Mirtazapine—Dizziness—Triamcinolone—atopic dermatitis	3.7e-05	0.000204	CcSEcCtD
Mirtazapine—Dizziness—Methylprednisolone—atopic dermatitis	3.69e-05	0.000204	CcSEcCtD
Mirtazapine—Feeling abnormal—Prednisone—atopic dermatitis	3.64e-05	0.000201	CcSEcCtD
Mirtazapine—Asthenia—Dexamethasone—atopic dermatitis	3.64e-05	0.000201	CcSEcCtD
Mirtazapine—Asthenia—Betamethasone—atopic dermatitis	3.64e-05	0.000201	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Prednisone—atopic dermatitis	3.61e-05	0.000199	CcSEcCtD
Mirtazapine—Nausea—Prednisolone—atopic dermatitis	3.61e-05	0.000199	CcSEcCtD
Mirtazapine—Pruritus—Dexamethasone—atopic dermatitis	3.59e-05	0.000198	CcSEcCtD
Mirtazapine—Pruritus—Betamethasone—atopic dermatitis	3.59e-05	0.000198	CcSEcCtD
Mirtazapine—Vomiting—Triamcinolone—atopic dermatitis	3.56e-05	0.000196	CcSEcCtD
Mirtazapine—Vomiting—Methylprednisolone—atopic dermatitis	3.55e-05	0.000196	CcSEcCtD
Mirtazapine—Nausea—Hydrocortisone—atopic dermatitis	3.53e-05	0.000195	CcSEcCtD
Mirtazapine—Rash—Triamcinolone—atopic dermatitis	3.53e-05	0.000195	CcSEcCtD
Mirtazapine—Dermatitis—Triamcinolone—atopic dermatitis	3.52e-05	0.000194	CcSEcCtD
Mirtazapine—Rash—Methylprednisolone—atopic dermatitis	3.52e-05	0.000194	CcSEcCtD
Mirtazapine—Dermatitis—Methylprednisolone—atopic dermatitis	3.52e-05	0.000194	CcSEcCtD
Mirtazapine—Urticaria—Prednisone—atopic dermatitis	3.51e-05	0.000194	CcSEcCtD
Mirtazapine—Headache—Triamcinolone—atopic dermatitis	3.5e-05	0.000193	CcSEcCtD
Mirtazapine—Headache—Methylprednisolone—atopic dermatitis	3.5e-05	0.000193	CcSEcCtD
Mirtazapine—Abdominal pain—Prednisone—atopic dermatitis	3.49e-05	0.000193	CcSEcCtD
Mirtazapine—Body temperature increased—Prednisone—atopic dermatitis	3.49e-05	0.000193	CcSEcCtD
Mirtazapine—Diarrhoea—Dexamethasone—atopic dermatitis	3.47e-05	0.000192	CcSEcCtD
Mirtazapine—Diarrhoea—Betamethasone—atopic dermatitis	3.47e-05	0.000192	CcSEcCtD
Mirtazapine—Dizziness—Dexamethasone—atopic dermatitis	3.36e-05	0.000185	CcSEcCtD
Mirtazapine—Dizziness—Betamethasone—atopic dermatitis	3.36e-05	0.000185	CcSEcCtD
Mirtazapine—Nausea—Triamcinolone—atopic dermatitis	3.32e-05	0.000183	CcSEcCtD
Mirtazapine—Nausea—Methylprednisolone—atopic dermatitis	3.32e-05	0.000183	CcSEcCtD
Mirtazapine—Hypersensitivity—Prednisone—atopic dermatitis	3.26e-05	0.00018	CcSEcCtD
Mirtazapine—Vomiting—Betamethasone—atopic dermatitis	3.23e-05	0.000178	CcSEcCtD
Mirtazapine—Vomiting—Dexamethasone—atopic dermatitis	3.23e-05	0.000178	CcSEcCtD
Mirtazapine—Rash—Betamethasone—atopic dermatitis	3.2e-05	0.000177	CcSEcCtD
Mirtazapine—Rash—Dexamethasone—atopic dermatitis	3.2e-05	0.000177	CcSEcCtD
Mirtazapine—Dermatitis—Betamethasone—atopic dermatitis	3.2e-05	0.000176	CcSEcCtD
Mirtazapine—Dermatitis—Dexamethasone—atopic dermatitis	3.2e-05	0.000176	CcSEcCtD
Mirtazapine—Headache—Betamethasone—atopic dermatitis	3.18e-05	0.000175	CcSEcCtD
Mirtazapine—Headache—Dexamethasone—atopic dermatitis	3.18e-05	0.000175	CcSEcCtD
Mirtazapine—Asthenia—Prednisone—atopic dermatitis	3.17e-05	0.000175	CcSEcCtD
Mirtazapine—Pruritus—Prednisone—atopic dermatitis	3.13e-05	0.000173	CcSEcCtD
Mirtazapine—Diarrhoea—Prednisone—atopic dermatitis	3.02e-05	0.000167	CcSEcCtD
Mirtazapine—Nausea—Dexamethasone—atopic dermatitis	3.02e-05	0.000166	CcSEcCtD
Mirtazapine—Nausea—Betamethasone—atopic dermatitis	3.02e-05	0.000166	CcSEcCtD
Mirtazapine—Dizziness—Prednisone—atopic dermatitis	2.92e-05	0.000161	CcSEcCtD
Mirtazapine—Vomiting—Prednisone—atopic dermatitis	2.81e-05	0.000155	CcSEcCtD
Mirtazapine—Rash—Prednisone—atopic dermatitis	2.79e-05	0.000154	CcSEcCtD
Mirtazapine—Dermatitis—Prednisone—atopic dermatitis	2.78e-05	0.000154	CcSEcCtD
Mirtazapine—Headache—Prednisone—atopic dermatitis	2.77e-05	0.000153	CcSEcCtD
Mirtazapine—Nausea—Prednisone—atopic dermatitis	2.63e-05	0.000145	CcSEcCtD
Mirtazapine—HRH3—Signaling Pathways—IL2—atopic dermatitis	1.12e-05	0.000184	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—IL5—atopic dermatitis	1.12e-05	0.000183	CbGpPWpGaD
Mirtazapine—HRH3—Signaling by GPCR—IL6—atopic dermatitis	1.12e-05	0.000183	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—CCL5—atopic dermatitis	1.12e-05	0.000182	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—CCR5—atopic dermatitis	1.11e-05	0.000181	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—CXCL10—atopic dermatitis	1.1e-05	0.00018	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—CCL5—atopic dermatitis	1.1e-05	0.00018	CbGpPWpGaD
Mirtazapine—OPRK1—GPCR downstream signaling—IL2—atopic dermatitis	1.1e-05	0.00018	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—ADSL—atopic dermatitis	1.09e-05	0.000179	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR downstream signaling—CCR5—atopic dermatitis	1.09e-05	0.000178	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—IL5—atopic dermatitis	1.09e-05	0.000178	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—CCR5—atopic dermatitis	1.09e-05	0.000178	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—CCR5—atopic dermatitis	1.09e-05	0.000178	CbGpPWpGaD
Mirtazapine—DRD4—GPCR downstream signaling—CXCL8—atopic dermatitis	1.08e-05	0.000177	CbGpPWpGaD
Mirtazapine—HTR7—GPCR downstream signaling—IL2—atopic dermatitis	1.08e-05	0.000177	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CCR3—atopic dermatitis	1.07e-05	0.000175	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—CCL5—atopic dermatitis	1.07e-05	0.000175	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—CCR5—atopic dermatitis	1.07e-05	0.000174	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—TAC1—atopic dermatitis	1.06e-05	0.000174	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—NPS—atopic dermatitis	1.06e-05	0.000174	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—NGF—atopic dermatitis	1.05e-05	0.000172	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—TAC1—atopic dermatitis	1.05e-05	0.000171	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—NPS—atopic dermatitis	1.05e-05	0.000171	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling by GPCR—CXCL8—atopic dermatitis	1.04e-05	0.000171	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—TAC1—atopic dermatitis	1.04e-05	0.000171	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—NPS—atopic dermatitis	1.04e-05	0.000171	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CXCR3—atopic dermatitis	1.04e-05	0.00017	CbGpPWpGaD
Mirtazapine—DRD4—GPCR downstream signaling—IL2—atopic dermatitis	1.04e-05	0.000169	CbGpPWpGaD
Mirtazapine—HTR2B—GPCR downstream signaling—CXCL8—atopic dermatitis	1.03e-05	0.000169	CbGpPWpGaD
Mirtazapine—HRH3—Signaling Pathways—MAPK8—atopic dermatitis	1.03e-05	0.000169	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—NGF—atopic dermatitis	1.03e-05	0.000169	CbGpPWpGaD
Mirtazapine—HTR7—Signaling by GPCR—CXCL8—atopic dermatitis	1.03e-05	0.000168	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CXCR3—atopic dermatitis	1.03e-05	0.000168	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—NPS—atopic dermatitis	1.02e-05	0.000167	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—TAC1—atopic dermatitis	1.02e-05	0.000167	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CXCR3—atopic dermatitis	1.02e-05	0.000167	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—CCR5—atopic dermatitis	1.02e-05	0.000167	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—CCL5—atopic dermatitis	1.02e-05	0.000167	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CXCR3—atopic dermatitis	1e-05	0.000164	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—CCR5—atopic dermatitis	1e-05	0.000164	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—CXCL10—atopic dermatitis	1e-05	0.000164	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling by GPCR—IL2—atopic dermatitis	9.98e-06	0.000163	CbGpPWpGaD
Mirtazapine—ADRA2A—Hemostasis—IL2—atopic dermatitis	9.97e-06	0.000163	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—CCR5—atopic dermatitis	9.91e-06	0.000162	CbGpPWpGaD
Mirtazapine—HTR2B—GPCR downstream signaling—IL2—atopic dermatitis	9.89e-06	0.000162	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—NGF—atopic dermatitis	9.89e-06	0.000162	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—IL5—atopic dermatitis	9.89e-06	0.000162	CbGpPWpGaD
Mirtazapine—DRD4—Signaling by GPCR—CXCL8—atopic dermatitis	9.84e-06	0.000161	CbGpPWpGaD
Mirtazapine—HTR7—Signaling by GPCR—IL2—atopic dermatitis	9.83e-06	0.000161	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—CXCL10—atopic dermatitis	9.82e-06	0.000161	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	9.73e-06	0.000159	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—IL5—atopic dermatitis	9.73e-06	0.000159	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—IL5—atopic dermatitis	9.71e-06	0.000159	CbGpPWpGaD
Mirtazapine—DRD3—GPCR downstream signaling—CXCL8—atopic dermatitis	9.63e-06	0.000157	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—CCR5—atopic dermatitis	9.62e-06	0.000157	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—CXCL10—atopic dermatitis	9.6e-06	0.000157	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—CXCL10—atopic dermatitis	9.55e-06	0.000156	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—IL5—atopic dermatitis	9.53e-06	0.000156	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—NPS—atopic dermatitis	9.52e-06	0.000156	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—TAC1—atopic dermatitis	9.52e-06	0.000156	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—CCL5—atopic dermatitis	9.48e-06	0.000155	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—NGF—atopic dermatitis	9.44e-06	0.000154	CbGpPWpGaD
Mirtazapine—DRD4—Signaling by GPCR—IL2—atopic dermatitis	9.41e-06	0.000154	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling by GPCR—CXCL8—atopic dermatitis	9.4e-06	0.000154	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CXCR3—atopic dermatitis	9.34e-06	0.000153	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—CXCL10—atopic dermatitis	9.29e-06	0.000152	CbGpPWpGaD
Mirtazapine—DRD3—GPCR downstream signaling—IL2—atopic dermatitis	9.2e-06	0.00015	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—CCR5—atopic dermatitis	9.18e-06	0.00015	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling by GPCR—IL2—atopic dermatitis	8.98e-06	0.000147	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—IL5—atopic dermatitis	8.85e-06	0.000145	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—GLB1—atopic dermatitis	8.81e-06	0.000144	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—NGF—atopic dermatitis	8.78e-06	0.000144	CbGpPWpGaD
Mirtazapine—ADRB1—GPCR downstream signaling—CXCL8—atopic dermatitis	8.77e-06	0.000143	CbGpPWpGaD
Mirtazapine—DRD3—Signaling by GPCR—CXCL8—atopic dermatitis	8.74e-06	0.000143	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—NFKBIA—atopic dermatitis	8.65e-06	0.000141	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—CCL5—atopic dermatitis	8.64e-06	0.000141	CbGpPWpGaD
Mirtazapine—ADRB2—GPCR downstream signaling—CXCL8—atopic dermatitis	8.58e-06	0.00014	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—CCR5—atopic dermatitis	8.54e-06	0.00014	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—NFKBIA—atopic dermatitis	8.52e-06	0.000139	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—CCL5—atopic dermatitis	8.45e-06	0.000138	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—ADSL—atopic dermatitis	8.45e-06	0.000138	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CXCL10—atopic dermatitis	8.43e-06	0.000138	CbGpPWpGaD
Mirtazapine—HTR1A—GPCR downstream signaling—CXCL8—atopic dermatitis	8.39e-06	0.000137	CbGpPWpGaD
Mirtazapine—ADRB1—GPCR downstream signaling—IL2—atopic dermatitis	8.38e-06	0.000137	CbGpPWpGaD
Mirtazapine—DRD3—Signaling by GPCR—IL2—atopic dermatitis	8.36e-06	0.000137	CbGpPWpGaD
Mirtazapine—HTR2C—GPCR downstream signaling—CXCL8—atopic dermatitis	8.35e-06	0.000136	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	8.32e-06	0.000136	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CXCL10—atopic dermatitis	8.3e-06	0.000136	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CXCL10—atopic dermatitis	8.28e-06	0.000135	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—CCL5—atopic dermatitis	8.27e-06	0.000135	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—PPARA—atopic dermatitis	8.26e-06	0.000135	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—CCL5—atopic dermatitis	8.22e-06	0.000134	CbGpPWpGaD
Mirtazapine—ADRB2—GPCR downstream signaling—IL2—atopic dermatitis	8.2e-06	0.000134	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—NFKBIA—atopic dermatitis	8.15e-06	0.000133	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CXCL10—atopic dermatitis	8.12e-06	0.000133	CbGpPWpGaD
Mirtazapine—ADRA2C—GPCR downstream signaling—CXCL8—atopic dermatitis	8.12e-06	0.000133	CbGpPWpGaD
Mirtazapine—HTR1A—GPCR downstream signaling—IL2—atopic dermatitis	8.02e-06	0.000131	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—NGF—atopic dermatitis	8e-06	0.000131	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—CCL5—atopic dermatitis	8e-06	0.000131	CbGpPWpGaD
Mirtazapine—HTR2C—GPCR downstream signaling—IL2—atopic dermatitis	7.98e-06	0.00013	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—CXCL8—atopic dermatitis	7.97e-06	0.00013	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—NGF—atopic dermatitis	7.83e-06	0.000128	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—CXCL8—atopic dermatitis	7.79e-06	0.000127	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—CCR5—atopic dermatitis	7.78e-06	0.000127	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—NFKBIA—atopic dermatitis	7.78e-06	0.000127	CbGpPWpGaD
Mirtazapine—ADRA2C—GPCR downstream signaling—IL2—atopic dermatitis	7.76e-06	0.000127	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—NGF—atopic dermatitis	7.65e-06	0.000125	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—CXCL8—atopic dermatitis	7.62e-06	0.000125	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—NGF—atopic dermatitis	7.62e-06	0.000124	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—CCR5—atopic dermatitis	7.62e-06	0.000124	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—IL2—atopic dermatitis	7.61e-06	0.000124	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—CXCL8—atopic dermatitis	7.58e-06	0.000124	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CXCL10—atopic dermatitis	7.55e-06	0.000123	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—IL2—atopic dermatitis	7.45e-06	0.000122	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—CCR5—atopic dermatitis	7.45e-06	0.000122	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—CCR5—atopic dermatitis	7.41e-06	0.000121	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—NGF—atopic dermatitis	7.41e-06	0.000121	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—CXCL8—atopic dermatitis	7.37e-06	0.000121	CbGpPWpGaD
Mirtazapine—DRD2—GPCR downstream signaling—CXCL8—atopic dermatitis	7.37e-06	0.00012	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—IL2—atopic dermatitis	7.28e-06	0.000119	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CCL5—atopic dermatitis	7.26e-06	0.000119	CbGpPWpGaD
Mirtazapine—HTR2A—GPCR downstream signaling—CXCL8—atopic dermatitis	7.25e-06	0.000119	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—IL2—atopic dermatitis	7.25e-06	0.000118	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—NFKBIA—atopic dermatitis	7.24e-06	0.000118	CbGpPWpGaD
Mirtazapine—HRH1—GPCR downstream signaling—CXCL8—atopic dermatitis	7.23e-06	0.000118	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—CCR5—atopic dermatitis	7.21e-06	0.000118	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CCL5—atopic dermatitis	7.14e-06	0.000117	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CCL5—atopic dermatitis	7.13e-06	0.000116	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR downstream signaling—CXCL8—atopic dermatitis	7.1e-06	0.000116	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—IL2—atopic dermatitis	7.05e-06	0.000115	CbGpPWpGaD
Mirtazapine—DRD2—GPCR downstream signaling—IL2—atopic dermatitis	7.04e-06	0.000115	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CCL5—atopic dermatitis	6.99e-06	0.000114	CbGpPWpGaD
Mirtazapine—HTR2A—GPCR downstream signaling—IL2—atopic dermatitis	6.93e-06	0.000113	CbGpPWpGaD
Mirtazapine—HRH1—GPCR downstream signaling—IL2—atopic dermatitis	6.91e-06	0.000113	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR downstream signaling—IL2—atopic dermatitis	6.78e-06	0.000111	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—NGF—atopic dermatitis	6.72e-06	0.00011	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—PPARA—atopic dermatitis	6.71e-06	0.00011	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—CXCL8—atopic dermatitis	6.69e-06	0.000109	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—NGF—atopic dermatitis	6.61e-06	0.000108	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—NFKBIA—atopic dermatitis	6.6e-06	0.000108	CbGpPWpGaD
Mirtazapine—HRH3—Signaling Pathways—IL6—atopic dermatitis	6.6e-06	0.000108	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—NGF—atopic dermatitis	6.6e-06	0.000108	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR downstream signaling—CXCL8—atopic dermatitis	6.6e-06	0.000108	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—CXCL8—atopic dermatitis	6.58e-06	0.000108	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—CXCL8—atopic dermatitis	6.57e-06	0.000107	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CCR5—atopic dermatitis	6.54e-06	0.000107	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CCL5—atopic dermatitis	6.5e-06	0.000106	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—NGF—atopic dermatitis	6.48e-06	0.000106	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—NFKBIA—atopic dermatitis	6.46e-06	0.000106	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—CXCL8—atopic dermatitis	6.45e-06	0.000105	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CCR5—atopic dermatitis	6.43e-06	0.000105	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CCR5—atopic dermatitis	6.42e-06	0.000105	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—IL2—atopic dermatitis	6.39e-06	0.000105	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—NFKBIA—atopic dermatitis	6.31e-06	0.000103	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR downstream signaling—IL2—atopic dermatitis	6.3e-06	0.000103	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CCR5—atopic dermatitis	6.3e-06	0.000103	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—IL2—atopic dermatitis	6.29e-06	0.000103	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—NFKBIA—atopic dermatitis	6.28e-06	0.000103	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—IL2—atopic dermatitis	6.28e-06	0.000103	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—CXCL8—atopic dermatitis	6.17e-06	0.000101	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—IL2—atopic dermatitis	6.16e-06	0.000101	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—NFKBIA—atopic dermatitis	6.11e-06	9.99e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—CXCL8—atopic dermatitis	6.08e-06	9.93e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—NGF—atopic dermatitis	6.02e-06	9.83e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—CXCL8—atopic dermatitis	5.99e-06	9.79e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—IL2—atopic dermatitis	5.9e-06	9.64e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling by GPCR—IL6—atopic dermatitis	5.87e-06	9.59e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CCR5—atopic dermatitis	5.85e-06	9.57e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—CXCL8—atopic dermatitis	5.82e-06	9.51e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—IL2—atopic dermatitis	5.81e-06	9.49e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling by GPCR—IL6—atopic dermatitis	5.78e-06	9.44e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—IL2—atopic dermatitis	5.72e-06	9.36e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—IL2—atopic dermatitis	5.56e-06	9.09e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—CXCL8—atopic dermatitis	5.55e-06	9.08e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—NFKBIA—atopic dermatitis	5.54e-06	9.06e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling by GPCR—IL6—atopic dermatitis	5.53e-06	9.04e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—NFKBIA—atopic dermatitis	5.45e-06	8.92e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—NFKBIA—atopic dermatitis	5.44e-06	8.9e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—MAPK8—atopic dermatitis	5.43e-06	8.87e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—MAPK8—atopic dermatitis	5.34e-06	8.74e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—NFKBIA—atopic dermatitis	5.34e-06	8.73e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PPARA—atopic dermatitis	5.33e-06	8.71e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—IL2—atopic dermatitis	5.31e-06	8.67e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling by GPCR—IL6—atopic dermatitis	5.28e-06	8.63e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—CXCL8—atopic dermatitis	5.17e-06	8.44e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—MAPK8—atopic dermatitis	5.12e-06	8.36e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—NFKBIA—atopic dermatitis	4.96e-06	8.11e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—IL2—atopic dermatitis	4.94e-06	8.07e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling by GPCR—IL6—atopic dermatitis	4.91e-06	8.03e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—MAPK8—atopic dermatitis	4.88e-06	7.98e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—CXCL8—atopic dermatitis	4.71e-06	7.69e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—CXCL8—atopic dermatitis	4.6e-06	7.53e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—MAPK8—atopic dermatitis	4.54e-06	7.43e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—CXCL8—atopic dermatitis	4.5e-06	7.36e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—IL2—atopic dermatitis	4.5e-06	7.35e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—CXCL8—atopic dermatitis	4.48e-06	7.32e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—IL6—atopic dermatitis	4.48e-06	7.32e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—IL2—atopic dermatitis	4.4e-06	7.19e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—IL6—atopic dermatitis	4.38e-06	7.16e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PPARA—atopic dermatitis	4.37e-06	7.15e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—CXCL8—atopic dermatitis	4.36e-06	7.12e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PPARA—atopic dermatitis	4.33e-06	7.09e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—IL2—atopic dermatitis	4.3e-06	7.03e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—IL6—atopic dermatitis	4.28e-06	7e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—IL2—atopic dermatitis	4.28e-06	7e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—IL6—atopic dermatitis	4.26e-06	6.96e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—IL2—atopic dermatitis	4.16e-06	6.81e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—IL6—atopic dermatitis	4.14e-06	6.77e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—MAPK8—atopic dermatitis	4.14e-06	6.77e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—MAPK8—atopic dermatitis	4.05e-06	6.62e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—MAPK8—atopic dermatitis	3.96e-06	6.47e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CXCL8—atopic dermatitis	3.95e-06	6.46e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—MAPK8—atopic dermatitis	3.94e-06	6.44e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CXCL8—atopic dermatitis	3.89e-06	6.36e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CXCL8—atopic dermatitis	3.88e-06	6.34e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—MAPK8—atopic dermatitis	3.83e-06	6.26e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CXCL8—atopic dermatitis	3.81e-06	6.23e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—IL2—atopic dermatitis	3.78e-06	6.18e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—IL6—atopic dermatitis	3.76e-06	6.14e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—IL2—atopic dermatitis	3.72e-06	6.08e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—IL2—atopic dermatitis	3.71e-06	6.06e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PPARA—atopic dermatitis	3.7e-06	6.06e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—IL6—atopic dermatitis	3.7e-06	6.05e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—IL6—atopic dermatitis	3.69e-06	6.03e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—IL2—atopic dermatitis	3.64e-06	5.95e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—IL6—atopic dermatitis	3.62e-06	5.92e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CXCL8—atopic dermatitis	3.54e-06	5.78e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—MAPK8—atopic dermatitis	3.48e-06	5.68e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—IL6—atopic dermatitis	3.47e-06	5.67e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—MAPK8—atopic dermatitis	3.42e-06	5.59e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—MAPK8—atopic dermatitis	3.41e-06	5.58e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—IL6—atopic dermatitis	3.41e-06	5.58e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—IL2—atopic dermatitis	3.38e-06	5.53e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—IL6—atopic dermatitis	3.36e-06	5.5e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—MAPK8—atopic dermatitis	3.35e-06	5.48e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—IL6—atopic dermatitis	3.27e-06	5.34e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—IL6—atopic dermatitis	3.12e-06	5.1e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—MAPK8—atopic dermatitis	3.11e-06	5.09e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—IL6—atopic dermatitis	2.9e-06	4.74e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PPARA—atopic dermatitis	2.86e-06	4.67e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—IL6—atopic dermatitis	2.64e-06	4.32e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—IL6—atopic dermatitis	2.59e-06	4.23e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—IL6—atopic dermatitis	2.53e-06	4.13e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—IL6—atopic dermatitis	2.52e-06	4.11e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—IL6—atopic dermatitis	2.45e-06	4e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—IL6—atopic dermatitis	2.22e-06	3.63e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—IL6—atopic dermatitis	2.18e-06	3.57e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—IL6—atopic dermatitis	2.18e-06	3.56e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—IL6—atopic dermatitis	2.14e-06	3.5e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—IL6—atopic dermatitis	1.99e-06	3.25e-05	CbGpPWpGaD
